Paul Cox | VP of IR and Corporate Communications |
Ryan Spencer | CEO |
Donn Casale | Chief Commercial Officer |
Rob Janssen | Chief Medical Officer |
Kelly MacDonald | CFO |
Matthew Phipps | William Blair |
Ernesto Rodriguez-Dumont | TD Cowen |
Roy Buchanan | JMP Securities |
Jonathan Miller | Evercore ISI |
Good day ladies and gentlemen, and welcome to Dynavax Technologies' Second Quarter 2023 Financial Results.
As a reminder, this conference is being recorded. At the end of the company's prepared remarks, we will open the call for questions and provide specific instructions at that point.
I would now like to turn the call over to Paul Cox, Vice President, Investor Relations and Corporate Communications.
You may begin.